miR-200c-3p (miR-200c) suppresses EMT and dephosphorylates AKT in endometrial cancer cells by targeting the BMI1 proto-oncogene polycomb ring finger (BMI-1) gene, which is reversed by miR-200c inhibition [61]. This evidence concerns the gene BMI1 and endometrial cancer.